Search

everythinglearnresearchcommunity

for

Search:↓

Upadacitinib improved symptoms and hair regrowth in a teen with multiple autoimmune conditions.

Compound 4 is a promising treatment for hair loss with low toxicity.

Topical ruxolitinib cream may help treat frontal fibrosing alopecia.

Tyrosine kinases are important in skin autoimmune diseases and could be targets for new treatments.

Baricitinib might help treat hair loss in lupus patients, but more research is needed.

Brevilin-A is a safe and effective treatment for mild to moderate alopecia areata in children.

Topical tofacitinib cream may help treat certain hair loss conditions with fewer risks.

Deucravacitinib helped a man regrow hair significantly.

Baricitinib can lead to hair regrowth in alopecia areata but may also cause relapses.

Baricitinib improved platelet counts and alopecia in a 16-year-old with chronic immune thrombocytopenia.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

Baricitinib is effective and safe for treating severe alopecia areata, promoting significant hair regrowth.

Certain drugs can change hair color, either lightening or darkening it.

Long-term baricitinib treatment can lead to significant scalp hair regrowth in patients initially showing only eyebrow or eyelash regrowth.

Ritlecitinib helps reduce inflammation and promote hair regrowth in alopecia areata, especially in patchy-type cases.

Tofacitinib was effective for severe, treatment-resistant hair loss without side effects.

No cure exists for alopecia areata, and treatments are personalized.

Cepharanthine may help treat COVID-19 by targeting similar pathways as other inflammatory diseases.

Ritlecitinib effectively treats alopecia areata and is well-tolerated.

Tofacitinib may be safe and effective for treating certain skin conditions in children.

Tofacitinib may help treat severe hair loss, but more research is needed.

Baricitinib for severe alopecia areata is generally safe, with common side effects like infections and acne, and low rates of serious complications.

Alopecia Areata is an autoimmune hair loss condition, with various treatments showing mixed effectiveness and no guaranteed cure.

Both baricitinib and tofacitinib effectively reduce alopecia areata severity, with tofacitinib showing more improvement over longer use.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

Alopecia Areata is an unpredictable autoimmune hair loss condition with limited and variable treatment effectiveness.

Combining baricitinib with UV-B therapy effectively treats non-segmental vitiligo and is well-tolerated.

Hair loss can be caused by cancer, treatments, or skin conditions, and trichoscopy helps diagnose it.

Deucravacitinib improves symptoms and reduces inflammation in Lichen Planopilaris.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.